Overview

Staccato Loxapine in Migraine (in Clinic)

Status:
Completed

Trial end date:
2007-12-01

Target enrollment:

Participant gender:

Summary

The objective of this trial is to assess the efficacy and safety of Staccato Loxapine in patients with migraine headache with or without aura in a clinical setting.

Phase:

Phase 2

Details

Lead Sponsor:

Alexza Pharmaceuticals, Inc.

Treatments:

Loxapine